BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 10208847)

  • 1. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction.
    Turner CA; Cooper S; Pulakat L
    Biochem Biophys Res Commun; 1999 Apr; 257(3):704-7. PubMed ID: 10208847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Arg182 in the second extracellular loop of angiotensin II receptor AT2 in ligand binding.
    Kurfis J; Knowle D; Pulakat L
    Biochem Biophys Res Commun; 1999 Oct; 263(3):816-9. PubMed ID: 10512763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction.
    Pulakat L; Tadessee AS; Dittus JJ; Gavini N
    Regul Pept; 1998 Jan; 73(1):51-7. PubMed ID: 9537673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Phe308 in the seventh transmembrane domain of the AT2 receptor in ligand binding and signaling.
    Pulakat L; Mandavia CH; Gavini N
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1138-43. PubMed ID: 15194486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the third intracellular loop of the angiotensin II receptor subtype AT2 in ligand-receptor interaction.
    Dittus J; Cooper S; Obermair G; Pulakat L
    FEBS Lett; 1999 Feb; 445(1):23-6. PubMed ID: 10069367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of angiotensin II type 2 (AT2) receptor domains mediating high-affinity CGP 42112A binding and receptor activation.
    Hines J; Heerding JN; Fluharty SJ; Yee DK
    J Pharmacol Exp Ther; 2001 Aug; 298(2):665-73. PubMed ID: 11454929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
    J Pept Res; 2004 Nov; 64(5):194-201. PubMed ID: 15485557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of angiotensin II receptor subtypes during testicular development in rats.
    Kanehara H; Song K; Hirai K; Ueda H; Shiota N; Azuma H; Katsuoka Y; Miyazaki H; Miyazaki M
    Int J Androl; 1998 Aug; 21(4):186-95. PubMed ID: 9749348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
    Weiland F; Verspohl EJ
    Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of a conserved fifth transmembrane domain lysine residue (Lys215) attenuates ligand binding in the angiotensin II type 2 receptor.
    Yee DK; Kisley LR; Heerding JN; Fluharty SJ
    Brain Res Mol Brain Res; 1997 Nov; 51(1-2):238-41. PubMed ID: 9427526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
    Schambye HT; Hjorth SA; Weinstock J; Schwartz TW
    Mol Pharmacol; 1995 Mar; 47(3):425-31. PubMed ID: 7700239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site.
    Ciuffo GM; Saavedra JM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1129-34. PubMed ID: 7562479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor.
    Pucell AG; Hodges JC; Sen I; Bumpus FM; Husain A
    Endocrinology; 1991 Apr; 128(4):1947-59. PubMed ID: 1848506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review.
    Lenkei Z; Palkovits M; Corvol P; Llorens-Cortès C
    Front Neuroendocrinol; 1997 Oct; 18(4):383-439. PubMed ID: 9344632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart.
    Wharton J; Morgan K; Rutherford RA; Catravas JD; Chester A; Whitehead BF; De Leval MR; Yacoub MH; Polak JM
    J Pharmacol Exp Ther; 1998 Jan; 284(1):323-36. PubMed ID: 9435195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
    Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of angiotensin II receptor internalization.
    Hunyady L
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S47-56. PubMed ID: 9892140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin AT2 receptor degradation is prevented by ligand occupation.
    Csikós T; Balmforth AJ; Grojec M; Gohlke P; Culman J; Unger T
    Biochem Biophys Res Commun; 1998 Feb; 243(1):142-7. PubMed ID: 9473495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
    Knock GA; Sullivan MH; McCarthy A; Elder MG; Polak JM; Wharton J
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1007-15. PubMed ID: 7965763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular structure and function of angiotensin ii receptors].
    Clauser E
    Nephrologie; 1998; 19(7):403-10. PubMed ID: 9857375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.